Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)

K-Number: K221826 · 2022-12-21

Decision Date2022-12-21
Product CodeJTN
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2022-12-21 under approval number K221826. The device is classified under product code JTN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)?

BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) is a medical device that received FDA 510(k) clearance on 2022-12-21. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K221826.

When was BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) approved by the FDA?

BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) received FDA 510(k) clearance on 2022-12-21, under approval number K221826.

What company makes BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)?

BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)?

The FDA product code for BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30) is JTN.

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: JTN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.